Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ropivacaine TAP Block Combined With IV Lidocaine in Colorectal Cancer Surgery
NCT06006026Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine in colorectal cancer (CRC), sponsored by West China Hospital of Sichuan University. Primary endpoint: Safety profile of combining ropivacaine and lidocaine at 24 hours. Started Aug 2023; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06006026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06006026.